The extensive induced fit molecular docking and dynamics studies provided insights into the mechanisms of action, highlighting strong interactions with key oncogenic proteins involved in RCC progression, as AXL, C‐RAF and LSD1. Here, AXL is linked to renal cell carcinoma.